|
|
Article: Bystander Transfer of GCV Nucleotides Enhance Killing.
- Article from:
- Gene Therapy Weekly
- Article date:
- March 8, 1999
- Author:
CopyrightCOPYRIGHT 1999 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
The efficiency of transfer of highly potent Ganciclovir (GCV) nucleotides may be responsible for the efficacy of bystander-mediated killing in herpes simplex virus (HSV) thymidine kinase (TK)/GCV suicide gene therapy.
In order to optimize HSV-TK/GCV gene therapy, more detailed studies on how the bystander effect works are needed. It is also important that the cells being studied are developed from the same parental cell line.
Laura Z. Rubsam and colleagues from the University of Michigan evaluated GCV cytotoxicity and nucleotide transfer in HSV-TK-expressing and bystander cells generated from a human glioblastoma cell line ("Cytotoxicity and Accumulation ...